NovoCure Ltd (NVCR) Insider Ownership

Historic Insider Ownership Trends

NVCR's three largest insider shareholders as of March 23, 2026 are Frank X Leonard (Chief Executive Officer, 493.79K shares), Ashley Cordova (Former Chief Executive Officer, 422.57K shares), Asaf Danziger (Director, 416.47K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Frank X Leonard Chief Executive Officer 493,793 0 05 Mar, 2026
Ashley Cordova Former Chief Executive Officer 422,570 0 05 Mar, 2026
Asaf Danziger 416,473 0 01 Jul, 2025
Uri Weinberg Chf Medical And Innovation Ofr 267,190 0 05 Mar, 2026
Arye Barak Ben General Counsel 242,453 0 05 Mar, 2026
Michal Nath Puri Chief Human Resources Officer 201,322 0 05 Mar, 2026
Christoph Brackmann Chief Financial Officer 182,842 0 05 Mar, 2026
W Anthony Vernon 179,102 0 06 Jun, 2025
Pritesh Shah Chief Growth Officer 124,511 0 08 Nov, 2023
Nicolas Leupin Former Chief Medical Officer 102,979 0 05 Mar, 2026
Mukund Paravasthu Chief Operating Officer 72,832 0 05 Mar, 2026
Moshe Giladi Chief Science Officer 69,771 0 29 Feb, 2024
William Patrick Burke Chief Human Resources Officer 66,447 0 06 Jul, 2023
Todd Christopher Longsworth General Counsel 62,462 0 09 Mar, 2022
Ely Benaim Chief Medical Officer 28,770 0 10 Jan, 2023
Martin J. Madden 18,674 0 04 Jun, 2025
Timothy J Scannell 17,233 0 06 Jun, 2025
Allyson J Ocean 14,269 0 06 Jun, 2025
Kristin Stafford 14,269 0 06 Jun, 2025
Martin J. Madden 0 384 06 Aug, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
03 Mar, 2026 Christoph Brackmann Ordinary Shares A 55,137 $0.00 189,254 D A
03 Mar, 2026 Mukund Paravasthu Ordinary Shares A 45,112 $0.00 121,455 D A
04 Mar, 2026 Ashley Cordova Ordinary Shares D 17,638 $13.30 422,570 D F
03 Mar, 2026 Arye Barak Ben Ordinary Shares A 50,125 $0.00 242,453 D A
04 Mar, 2026 Nicolas Leupin Ordinary Shares D 1,100 $13.31 102,979 D S
03 Mar, 2026 Frank X Leonard Ordinary Shares A 150,000 $0.00 499,400 D A
03 Mar, 2026 Michal Nath Puri Ordinary Shares A 40,100 $0.00 202,422 D A
03 Mar, 2026 Uri Weinberg Ordinary Shares A 50,125 $0.00 273,602 D A
04 Mar, 2026 Uri Weinberg Ordinary Shares D 6,412 $13.31 267,190 D S
03 Mar, 2026 Arye Barak Ben Stock Option (Right to Buy) A 73,340 $0.00 73,340 D A
04 Mar, 2026 Christoph Brackmann Ordinary Shares D 6,412 $13.31 182,842 D S
04 Mar, 2026 Mukund Paravasthu Ordinary Shares D 5,377 $13.31 116,078 D S
04 Mar, 2026 Michal Nath Puri Ordinary Shares D 1,100 $13.31 201,322 D S
04 Mar, 2026 Frank X Leonard Ordinary Shares D 5,607 $13.31 493,793 D S
03 Mar, 2026 Uri Weinberg Stock Option (Right to Buy) A 73,340 $0.00 73,340 D A
05 Mar, 2026 Mukund Paravasthu Ordinary Shares D 43,246 $13.77 72,832 D S
03 Mar, 2026 Frank X Leonard Stock Option (Right to Buy) A 216,388 $0.00 216,388 D A
03 Mar, 2026 Christoph Brackmann Stock Option (Right to Buy) A 80,674 $0.00 80,674 D A
03 Mar, 2026 Michal Nath Puri Stock Option (Right to Buy) A 58,672 $0.00 58,672 D A
03 Mar, 2026 Mukund Paravasthu Stock Option (Right to Buy) A 7,518 $0.00 7,518 D A